Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2721200 | The American Journal of Medicine | 2006 | 6 Pages |
Abstract
The clinical use of caspofungin has been successful in the treatment of invasive candidiasis, even in patients with prior antifungal exposure. In this unselected review, caspofungin performed similarly as in clinical trials, and clinicians should consider caspofungin as first-line therapy for invasive candidiasis, particularly non-albicans species.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Aimee K. MD, Elizabeth S. PharmD, BCPS, Barbara D. MD, Melissa D. PharmD, John R. MD,